Stefanie Bader

Such a pleasure talking with you today – about science and everything in between! Really looking forward to seeing where your ideas go – exciting times ahead!

12.06.2025 19:21 — 👍 0    🔁 0    💬 0    📌 0

Thank you for sharing Pauline - and I’m sorry to hear what you’re going through. Stories like yours are a big part of why we do this work! We’re hopeful that this research is a step toward real solutions for long COVID, and we’re not stopping here :)

09.04.2025 23:19 — 👍 1    🔁 0    💬 0    📌 0

A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID - Nature Communications A novel antiviral targeting the SARS-CoV-2 PLpro protease shows strong efficacy in a mouse model, preventing lung pathology and reducing brain dysfunction. The study provides proof-of-principle that P...

Excited to share that our collaborative work on PLpro inhibitors is published! Using a model that replicates symptoms seen in long COVID patients, we show that a potent antiviral can prevent long-term disease. A big step forward in long COVID therapy. #LongCOVID #PLpro #COVID19 #SARSCoV2 #Antivirals

09.04.2025 03:58 — 👍 24    🔁 5    💬 2    📌 0

AI for research: the ultimate guide to choosing the right tool Curious about using artificial intelligence to boost your research? Here are the programs you shouldn’t miss.

Curious about using artificial intelligence to boost your research? Here are the programs you shouldn’t miss

https://go.nature.com/3RFlouC

07.04.2025 17:29 — 👍 53    🔁 13    💬 0    📌 2

In <24 hours, Covid funding is DOGEd across HHS, CDC, NIH as if it and Long Covid didn't exist and there is no worry for future pandemics
www.science.org/content/arti...
www.nbcnews.com/health/healt...
www.science.org/content/arti...

25.03.2025 22:30 — 👍 3271    🔁 1388    💬 195    📌 148

A fantastic morning hosting 2 exceptional #celldeath researchers at the 2025 #ACDS Welcome Seminar!

Seth Masters shared his exciting research program exploring NLRP mutations in patients with inflammatory disease. Similarly, Aysha Al-Ani showed us the power of combining bedside-bench IBD research 🔥

05.03.2025 02:08 — 👍 7    🔁 4    💬 1    📌 0

Antiviral covalent ACE2 vesicle spray Meng et al. developed a covalently engineered ACE2 nanovesicle spray (nanoSpray) for antiviral therapeutics. This nanoSpray irreversibly neutralized SARS-CoV-2 in vitro and showed an approximately 20-...

Still in the pre-clinical, animal testing phase, but this looks very promising. As the US embraces 1901 & detaches from science & evidence-based reality, China is moving fast to take full advantage in R&D. Antiviral covalent ACE2 vesicle spray: Cell Biomaterials www.cell.com/cell-biomate...

05.03.2025 00:46 — 👍 23    🔁 11    💬 2    📌 1

So honored to have been awarded an NHMRC investigator grant! 🤗

Thank you to my mentors, our amazing lab team, and everyone who has supported my journey.
I’m looking forward to the work ahead! 🌍🔬

#LongCOVID #Research #NHMRC #InvestigatorGrant #WEHIResearch

01.03.2025 01:22 — 👍 5    🔁 0    💬 0    📌 0

What better way to make my first post on Bluesky than to celebrate a blue sky win? 🙃 Thrilled to receive WEHI’s Award for Blue Sky Research, to develop a whole-body imaging platform to visualize inflammation in long COVID🔬Huge thanks to Jenny Tatchell for helping turn our ideas into reality!

07.12.2024 05:47 — 👍 9    🔁 0    💬 0    📌 0